Genomatica
San Diego, US · Founded 2000 · Delaware corporation · 218 employees on LinkedIn · 3 known investors
Genomatica (Geno) develops biotechnology processes to produce bio-based chemicals and materials—such as 1,4-butanediol (BDO), butylene glycol for cosmetics, and plant-based nylon—as alternatives to fossil-fuel-derived inputs. It licenses and scales these technologies with industrial partners across the chemicals, beauty, and materials industries in the US, Europe, and Asia.
Founders & leadership
Genomatica was founded in 2000 by Christophe Schilling and Bernhard Palsson.
Investors · 3
Reported raises · per SEC filings
Form D private placements$125.9M disclosed across 2 rounds · 2014–2021
▶$119.1MraisedAug 2021 · 11 investors · Other TechnologyRule 506(b)
- Rasmus von GottbergExecutive Officer
- Thomas McDonaldExecutive Officer
- Christophe SchillingExecutive Officer, Director
- Craig BinettiDirector
- David MuldoonExecutive Officer
- Anders Bendsen SpohrDirector
- Jason KellyDirector
- Eli CasdinDirector
- Carlos A. CabreraExecutive Officer, Director
- Offering amount
- $119.1M
- Amount sold
- $119.1M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.8MraisedMar 2014 · 12 investors · Other TechnologyRule 506(b)
- Christophe SchillingExecutive Officer, Director
- Josh GreenDirector
- Jeff LievenseExecutive Officer
- Warren ClarkDirector
- Just JanszDirector
- Thomas J.G. HuotDirector
- Mark BurkExecutive Officer
- Michael KeaneExecutive Officer
- Geoff DuykDirector
- William H. BaumExecutive Officer, Director
- Leighton ReadDirector
- Offering amount
- $12.4M
- Amount sold
- $6.8M
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Genomatica went on to found or lead other companies.
Competitors · 1
by search overlap
Companies competing with Genomatica for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Genomatica do?
- Genomatica (Geno) develops biotechnology processes to produce bio-based chemicals and materials—such as 1,4-butanediol (BDO), butylene glycol for cosmetics, and plant-based nylon—as alternatives to fossil-fuel-derived inputs. It licenses and scales these technologies with industrial partners across the chemicals, beauty, and materials industries in the US, Europe, and Asia.
- Who founded Genomatica?
- Genomatica was founded by Christophe Schilling, Bernhard Palsson in 2000.
- Who are Genomatica's investors?
- Genomatica's investors include VantagePoint Capital Partners, Casdin Capital, Novo Holdings.
- How much funding has Genomatica raised?
- Genomatica has disclosed $125.9M raised across 2 rounds.
- Where is Genomatica headquartered?
- Genomatica is headquartered in San Diego, US.